Fennec Announces Appointment of Marco Brughera to the Board of Directors
RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 08/11/16 -- Fennec Pharmaceuticals Inc. (TSX: FRX)(OTCQB: FENCF), a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum- …